| Literature DB >> 31588668 |
Peter Bock1, Colette Gunst2,3, Leonard Maschilla2, Rory Holtman4, Nelis Grobbelaar5, Dillon Wademan1, Rory Dunbar1, Geoffrey Fatti6,7, James Kruger4, Nathan Ford8, Graeme Hoddinott1, Sue-Ann Meehan1.
Abstract
INTRODUCTION: Differentiated models of care that include referral of antiretroviral treatment (ART) clients to adherence clubs are an important strategy to help clinics manage increased number of clients living with HIV in resource-constrained settings. This study reported on (i) clinical outcomes among ART clients attending community-based adherence clubs and (ii) experiences of adherence clubs and perceptions of factors key to successful adherence club implementation among clients and healthcare workers.Entities:
Keywords: zzm321990HIVzzm321990; adherence clubs; antiretroviral treatment; clients’ perceptions; differentiated care; factors key for success; lost to follow-up; retention in care; staff perceptions
Mesh:
Substances:
Year: 2019 PMID: 31588668 PMCID: PMC6778813 DOI: 10.1002/jia2.25396
Source DB: PubMed Journal: J Int AIDS Soc ISSN: 1758-2652 Impact factor: 5.396
Simplified eligibility criteria for adherence club referral of stable ART clients
| Inclusion criteria |
| Adult ≥18 years (adolescents could be seen in a support group/specific time as requested by them) |
| Must be on current ART regime ≥6 months. If there has been a single drug substitution, the clinician to determine when the patient is eligible for adherence clubs |
| Most recent (taken in past 6 months) viral load <400 copies/mL |
| ART adherence ≥90% |
| Patient agrees to receive care through the adherence club system |
| Exclusion criteria |
| Pregnant |
| Active tuberculosis |
Taken from appendix C, Cape Winelands District Guideline for the distribution of pre‐packed medication to stable clients on chronic disease medication at “Fast‐Lane” or “Club” 19.
Baseline characteristics
| Clinic n (%) | ART Club n (%) | Total n (%) |
| |
|---|---|---|---|---|
| Study sample | ||||
| N | 263 (56.6) | 202 (43.4) | 465 (100) | |
| Gender | ||||
| Female | 156 (59.3) | 143 (70.8) | 299 (64.3) | 0.010 |
| Male | 107 (40.7) | 59 (29.2) | 166 (35.7) | |
| Age (years) | ||||
| Median (IQR) | 32 (27 to 41) | 32 (27 to 40) | 32 (27 to 40) | 0.919 |
| 18 to 25 | 56 (21.3) | 40 (19.8) | 96 (20.7) | 0.963 |
| 26 to 35 | 108 (41.1) | 84 (41.6) | 192 (41.3) | |
| 36 to 45 | 61 (23.2) | 46 (22.8) | 107 (23) | |
| >45 | 38 (14.5) | 32 (15.8) | 70 (15.1) | |
| Pregnant at ART start | ||||
| Yes | 22 (14.1) | 25 (17.5) | 47 (15.7) | 0.155 |
| Baseline CD4 count (cells/μL) | ||||
| Median (IQR) | 345 (198 to 508) | 399 (289 to 539) | 375 (234 to 532) | 0.004 |
| 0 to 200 | 67 (25.5) | 26 (12.9) | 93 (20) | 0.010 |
| 201 to 250 | 65 (24.7) | 49 (24.3) | 114 (24.5) | |
| 351 to 500 | 61 (23.2) | 64 (31.7) | 125 (26.9) | |
| >500 | 68 (25.9) | 62 (30.7) | 130 (28) | |
| Missing | 2 (0.8) | 1 (0.5) | 3 (0.7) | |
| Previous ART exposure | ||||
| None | 240 (91.3) | 177 (87.6) | 417 (89.7) | 0.077 |
| PMTCT | 18 (6.8) | 24 (11.9) | 42 (9) | |
| >30 days | 5 (1.9) | 1 (0.5) | 6 (1.3) | |
| Baseline TB | ||||
| None | 226 (85.9) | 192 (95.1) | 418 (89.9) | 0.002 |
| Yes | 33 (12.6) | 7 (3.5) | 40 (8.6) | |
| Missing | 4 (1.5) | 3 (1.5) | 7 (1.5) | |
| Year of ART start | ||||
| 2014 | 125 (47.5) | 101 (50) | 226 (48.6) | 0.597 |
| 2015 | 138 (52.5) | 101 (50) | 239 (51.4) | |
Denominator for % = number of women in clinic or ART group. For all other factors denominator for % = N.
Figure 1Outline of client outcomes over follow‐up period.
Figure 2Kaplan‐Meier estimate of UTFU.
Restricted to 451 clients Excluded 14 who reverted to clinic after referral to a clinic‐ or community‐based adherence club. Log‐rank test for equality of survivor functions p < 0.001.
Figure 3Kaplan‐Meier estimate of LTFU status restricted clients eligible for adherence club referral.
Restricted to 294 clients who were eligible for clinic or community‐based adherence club referral and remained in adherence club care after adherence club referral. Log‐rank for equality of survivor functions p < 0.001.
Cox regression of baseline factors and LTFU
| Crude hazard ratio (95% CI) | Adjusted hazard ratio (95% CI) |
| ||
|---|---|---|---|---|
| Referred to club | ||||
| Yes | 0.29 (0.14 to 0.64) | 0.002 | 0.25 (0.11 to 0.56) | 0.001 |
| No | 1 | 1 | ||
| Gender | ||||
| Male | 0.95 (0.63 to 1.42) | 0.798 | 1.09 (0.7 to 1.69) | 0.704 |
| Female | 1 | 1 | ||
| Age category (years) | ||||
| 15 to 25 | 1.48 (0.9 to 2.43) | 0.067 | 1.45 (0.86 to 2.45) | 0.067 |
| 26 to 35 | 1 | 1.0 | ||
| 36 to 45 | 1.08 (0.64 to 1.83) | 1.12 (0.66 to 1.91) | ||
| >45 | 0.71 (0.34 to 1.46) | 0.75 (0.36 to 1.58) | ||
| Baseline CD4 (cells/μL) | ||||
| > 500 | 1 | 0.008 | 1.0 | 0.009 |
| 351 to 500 | 0.71 (0.42 to 1.2) | 0.62 (0.36 to 1.05) | ||
| 201 to 350 | 0.69 (0.4 to 1.19) | 0.68 (0.39 to 1.19) | ||
| 0 to 200 | 0.69 (0.38 to 1.25) | 0.63 (0.33 to 1.19) | ||
| Pregnant at baseline | ||||
| Yes | 1.69 (0.9 to 3.18) | 0.101 | 1.79 (0.89 to 3.63) | 0.103 |
| Baseline TB | ||||
| Yes | 1.29 (0.69 to 2.42) | 0.427 | 1.41 (0.73 to 2.73) | 0.306 |
| Year ART start | ||||
| 2014 | 1 | 1.0 | ||
| 2015 | 1.38 (0.89 to 2.13) | 0.151 | 1.60 (1.00 to 2.57) | 0.049 |
This analysis was restricted to 451 clients, excluding 14 who reverted to clinic care after referral to a community‐based adherence club.
Cox regression of baseline factors and LTFU restricted to patients eligible for adherence club referral
| Crude hazard ratio (95% CI) |
| Adjusted hazard ratio (95% CI) |
| |
|---|---|---|---|---|
| Referred to club | ||||
| Yes | 0.33 (0.14 to 0.74) | 0.007 | 0.28 (0.12 to 0.65) | 0.003 |
| No | 1.0 | 1.0 | ||
| Gender | ||||
| Male | 1.34 (0.76 to 2.37) | 0.314 | 1.4 (0.78 to 2.51) | 0.255 |
| Female | 1.0 | 1.0 | ||
| Age category (years) | ||||
| 15 to 25 | 1.66 (0.85 to 3.25) | 0.210 | 1.79 (0.85 to 3.8) | 0.215 |
| 26 to 35 | 1.0 | 1.0 | ||
| 36 to 45 | 0.71 (0.31 to 1.61) | 0.65 (0.3 to 1.41) | ||
| >45 | 0.79 (0.3 to 2.1) | 0.84 (0.31 to 2.29) | ||
| Baseline CD4 (cells/μL) | ||||
| >500 | 1.0 | 1.0 | 0.354 | |
| 351 to 500 | 0.85 (0.4 to 1.8) | 0.436 | 0.73 (0.35 to 1.52) | |
| 201 to 350 | 0.95 (0.43 to 2.1) | 0.94 (0.42 to 2.11) | ||
| 0 to 200 | 1.29 (0.53 to 3.14) | 1.42 (0.58 to 3.46) | ||
| Year ART start | ||||
| 2014 | 1.0 | 1.0 | 0.012 | |
| 2015 | 1.95 (1.01 to 3.74) | 0.045 | 2.31 (1.21 to 4.42) | |
This analysis was restricted to 292 clients who were eligible for community‐based adherence club referral (on the same ART regimen for >6 months, not pregnant at baseline, no active TB at baseline) and remained in adherence club care after adherence club referral.
Viral load suppression rates
| 0 to 6 Months ART | 7 to 12 Months ART | 13 to 24 Months ART | Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VLD | VLS (n) | VLS % (95% CI) | VLD | VLS (n) | VLS % (95% CI) | VLD | VLS (n) | VLS % (95% CI) | VLD | VLS (n) | VLS % (95% CI) | |
| Clinic | 157 | 137 | 87.3 (81.0 to 92.0) | 100 | 91 | 91.0 (83.6 to 95.8) | 52 | 40 | 76.9 (63.2 to 87.5) | 309 | 268 | 86.7 (82.4 to 90.3) |
| Adherence club | 5 | 5 | 100 | 31 | 28 | 90.3 (74.2 to 97.9) | 43 | 42 | 97.0 (87.7 to 99.9) | 79 | 75 | 94.9 (87.5 to 98.6) |
| Total | 162 | 142 | 87.7 (81.6 to 92.3) | 131 | 119 | 90.8 (85.5 to 95.2) | 95 | 82 | 86.3 (77.7 to 92.5) | 388 | 343 | 88.4 (84.8 to 91.4) |
VLD, Viral load done and reported; VLS, Viral load suppressed.
Figure 4Client experiences of community‐based adherence club (n = 37).
Restricted to clients attending a community‐based adherence club.
Figure 5Healthcare worker perceptions of adherence clubs (n = 12).